Market Overview:
The global anxiolytics market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of anxiety disorders, rising geriatric population, and growing demand for prescription drugs. The global anxiolytics market is segmented on the basis of type into tablets and capsules. The capsules segment is expected to grow at a higher CAGR than the tablets segment during the forecast period from 2018 to 2030. This can be attributed to their high efficacy and better patient compliance as compared with tablets. On the basis of application, the global anxiolytics market is divided into hospital pharmacies, drug stores, and others (including clinics and research institutes). The hospital pharmacies segment dominates this market owing to increased use of these drugs for treating various psychiatric disorders in hospitals across different regions worldwide.
Product Definition:
Anxiolytics are a class of drugs used to treat anxiety disorders. They include benzodiazepines, such as alprazolam (Xanax) and diazepam (Valium), and barbiturates, such as phenobarbital (Luminal) and secobarbital sodium (Seconal).
Tablets:
Tablets are small, flat and rigid containers made of plastic or paper. They come in different forms such as disintegrating tablets, effervescent tablets and film-coated tablets. Tablets have a high demand in the market due to their cost efficiency as compared to other dosage forms like liquids and capsules which has led to its increased usage over the past few years.
Capsules:
Capsules are small containers made up of gelatin, aluminum, and other materials. It is used to preserve medicines or drugs which help in smooth delivery of the drug to the patient. The size and shape of capsule depends upon the dosage form which can be oral tablets, capsules or even sublingual tablets. Capsules have a hard shell that protects medicine from external impact while swallowing and also delivers it quickly into the stomach without allowing it to degrade or get contaminated.
Application Insights:
Based on the application, the global anxiolytics market has been segmented into hospital pharmacies, drug stores and others. The drug stores are anticipated to dominate the market throughout the forecast period owing to increasing usage of anxiety-relieving drugs in various clinical applications such as insomnia, nerve pain and migraine.
The other application segment includes clinics/family medicine physicians' offices. Increasing use of anxiolytic drugs in outpatient settings is driving this segment due to convenience associated with self-administration of medication without a doctor¢â‚¬â„¢s prescription. Furthermore, growing awareness about anxiety disorders among patients suffering from these conditions is expected to drive demand for anxiolytics over the forecast period.
In addition, manufacturers are entering into new markets through product innovation.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to high product demand and wide usage of anxiolytics in various medical conditions, such as panic disorder, social anxiety disorder, and generalized anxiety disorder. Moreover, increasing cases of mental health disorders are also contributing toward growth in this region. According to a study published by Columbia University Mailman School of Public Health in 2015; around 41% of adults experienced symptoms or consulted a doctor for mental health issues in the past year across U.S., Canada, and Mexico.
Asia Pacific is anticipated to be one of the fastest-growing regions over the forecast period due to rising geriatric population with associated stress & anxiety levels coupled with changing lifestyles resulting from economic independency among men.
Growth Factors:
- Increasing prevalence of anxiety disorders: The global prevalence of anxiety disorders is estimated to be around 7%–13%. This number is expected to grow in the coming years due to various factors such as increasing stress levels, changing lifestyle patterns, and growing awareness about mental health. This will create a larger patient population for anxiolytics drugs.
- Growing use of combination therapies: A large number of patients do not respond adequately to a single drug therapy for anxiety disorder and hence require combination therapy. The use of multiple drugs leads to increased sales opportunities for the anxiolytic market players.
- Launch of novel products: The development pipeline for anxiolytic drugs is quite robust with many new molecules being developed by pharmaceutical companies. These novel products are likely to be launched in the next few years, providing growth opportunities for the market players involved in this space.
Scope Of The Report
Report Attributes
Report Details
Report Title
Anxiolytics Market Research Report
By Type
Tablets, Capsules
By Application
Hospital Pharmacies, Drug Stores, Others
By Companies
Johnson and Johnson, Bristol-Myers Squibb, AstraZeneca, Novartis, Allergan, Pfizer, GlaxoSmithKline
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
142
Number of Tables & Figures
100
Customization Available
Yes, the report can be customized as per your need.
Global Anxiolytics Market Report Segments:
The global Anxiolytics market is segmented on the basis of:
Types
Tablets, Capsules
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Drug Stores, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson and Johnson
- Bristol-Myers Squibb
- AstraZeneca
- Novartis
- Allergan
- Pfizer
- GlaxoSmithKline
Highlights of The Anxiolytics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablets
- Capsules
- By Application:
- Hospital Pharmacies
- Drug Stores
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Anxiolytics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Anxiolytics are medications that help to reduce anxiety. They can be prescribed to people who suffer from anxiety disorders, or they can be used as a preventive measure for those who do not have an anxiety disorder but may experience occasional bouts of stress.
Some of the major players in the anxiolytics market are Johnson and Johnson, Bristol-Myers Squibb, AstraZeneca, Novartis, Allergan, Pfizer, GlaxoSmithKline.
The anxiolytics market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Anxiolytics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Anxiolytics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Anxiolytics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Anxiolytics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Anxiolytics Market Size & Forecast, 2020-2028
4.5.1 Anxiolytics Market Size and Y-o-Y Growth
4.5.2 Anxiolytics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Tablets
5.2.2 Capsules
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Drug Stores
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Anxiolytics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Anxiolytics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Tablets
9.6.2 Capsules
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Drug Stores
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Tablets
10.6.2 Capsules
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Drug Stores
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Tablets
11.6.2 Capsules
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Drug Stores
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Tablets
12.6.2 Capsules
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Drug Stores
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Tablets
13.6.2 Capsules
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Drug Stores
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Anxiolytics Market: Competitive Dashboard
14.2 Global Anxiolytics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson and Johnson
14.3.2 Bristol-Myers Squibb
14.3.3 AstraZeneca
14.3.4 Novartis
14.3.5 Allergan
14.3.6 Pfizer
14.3.7 GlaxoSmithKline
